Spasmolytic (Otilonium Bromide) Use in Upper Gastrointestinal Endoscopy: Randomized Prospective Trial

Konya Meram State Hospital0 sites400 target enrollmentJanuary 2013

ConditionsGastroscopy

Interventionsotilonium bromide

Drugsotilonium bromide

Overview

Phase: Phase 4
Intervention: otilonium bromide
Conditions: Gastroscopy
Sponsor: Konya Meram State Hospital
Enrollment: 400
Primary Endpoint: motility
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Similar Trials

Overview

Brief Summary

Upper gastrointestinal system endoscopy is widely used for diagnostic approach. To increase the tolerability and compliance of the patient, sedation is applied. There are many studies showing that sedation increases the patient compliance and the tolerability. However, spasmolytic use in GE has not been evaluated yet.

Registry

clinicaltrials.gov

Start Date

January 2013

End Date

June 2013

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Konya Meram State Hospital

Responsible Party

Principal Investigator

barış sevinç

M. D.

Konya Meram State Hospital

Eligibility Criteria

Inclusion Criteria

•no hypersensitivity to the agent.

Exclusion Criteria

•Emergent cases,the cases with low mental compatibility and pregnant women were excluded from the study. Moreover, the procedures under sedation, cases with disorders decreasing the intestinal motility like hypothyroidism and diabetes were excluded.